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Abstrakt
Glukokortikoidy jsou skupina steroidních hormonů, které jsou syntetizovány v 
nadledvinách. Vykonávají četné funkce související s metabolismem, imunitní odpovědí a 
ontogenezí. Glukokortikoidy účinkují jako výkonné molekuly hypothalamo-hypofýzo-
nadledvinové (HPA) osy a jako takové je jejich hladina v krvi zvýšena po vystavení stresu. 
Bazální hladina glukokortikoidů také vykazuje nápadný denní rytmus svědčící o vlivu 
cirkadiánních hodin na regulaci HPA osy. Studie ukázaly, že na regulaci denní sekrece 
glukokortikoidů se kromě HPA osy podílí i další regulační mechanismy. Poruchy těchto 
regulačních mechanismů mohou vést k vážných patologiím. Tato práce popisuje  podstatu 
rytmické povahy výlevu glukokortikoidů a mechanismy, kterými cirkadiánní hodiny uplatňují 
svůj vliv na zmíněný rytmus. Dále se práce stručně zaměřuje na vysvětlení povahy zpětné 
vazby glukokortikoidů na hodinový systém. Závěrem jsou shrnuty některé příklady úlohy 
abnormální sekrece glukokortikoidů v několika vybraných chorobách.
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Abstract
Glucocorticoids belong to a family of steroid hormones synthesized in the adrenal 
gland. They fulfill a variety of functions related to metabolism, immune response and 
ontogenesis. Glucocorticoids function as the end-effector of hypothalamic-pituitary-adrenal 
(HPA) axis and as such, their levels in blood are elevated after exposure to stressors. The 
basal levels of glucocorticoid also show a pronounced diurnal rhythm, suggesting 
involvement of the circadian clock in the regulation of HPA axis. Studies have shown that 
other regulatory mechanisms apart from the HPA axis are involved in regulation of diurnal 
glucocortioid secretion. The disturbances of the regulatory mechanisms may lead to serious 
pathological conditions. This thesis describes the rhythmic nature of glucocorticoid release 
and mechanisms by which the circadian clock exerts its influence over the rhythm. Thereafter, 
the feedback of glucocorticoids onto the clock system is briefly explained. Finally, some 
examples of a role of abnormal glucocorticoid secretion in selected pathologies are provided.
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Due  to  the  presence  of  day-night  cycles  on  Earth,  organisms  began  to  integrate 
mechanisms that allowed them to optimize their behavioral activity and internal functions. 
These mechanisms are now present at many different levels and act through both humoral and 
neural  mechanisms.  By  doing  so,  organisms  could  anticipate  periodic  changes  in  their 
surroundings and make necessary precautions, hence gaining an evolutionary advantage over 
their  peers  and  dominating  the  planetary  ecology.  We  call  these  mechanisms  "biological 
clocks". The clocks that oversee daily rhythms are called "circadian clocks". (in latin "circa 
diem" means "approximately a day") 
The  molecular  makeup  of  circadian  clocks  is  composed  of  self-sustaining 
transcriptional-translational feedback loops, a principle well conserved among organisms. Its 
complexity varies from the simple clock in cyanobacteria to rather complicated mammalian 
clock. In order to achieve such a higher level of coordination needed to keep several systems 
in synchrony, mammals harbor a central, or "master" circadian clock, which directly receives 
information from the outside world and then relays it to other clocks in peripheral tissues.  
In mammals, some parts of the endocrine system are under tight circadian regulation, 
including an  important  endocrine  organ,  the  adrenal  gland.  One of  the  hormone families 
secreted by the adrenal gland are glucocorticoids. Glucocorticoid secretion follows diurnal 
pattern under normal circumstances and if the organism loses its inherent rhythmicity,  the 
rhythm of secretion generally disappears as well. 
The rhythm of glucocorticoids and its persistence in an organism are very important. If 
not  present,  serious  pathological  consequences  may develop.  It  is  therefore  important  to 
understand the mechanisms that govern over its rhythmicity. The aim of this work is thus i) to 
reiterate  the  characteristics  of  glucocorticoids,  ii)  to  underline  the  basic  mechanisms  and 
outlook of mammalian circadian clockwork, iii) to summarize the mechanisms by which the 
clock  influences  adrenal  gland  function  and  glucocorticoid  secretion  and  iv)  to  provide 
examples of several disorders which are linked with abnormal glucocorticoid secretion.
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2 Glucocorticoids and their synthesis
Glucocorticoids are adrenocortical hormones of steroid nature synthesized in adrenal 
gland (Payne 2004),  whose action is  tightly linked with intermediate  metabolism and the 
stress  response.  The  member  of  glucocorticoid  family  found  in  human  body  in  largest 
volumes is cortisol, while many other mammals, such as rodents, utilize corticosterone in its 
place.  Glucocorticoids  show a  wide  array  of  physiological  effects  throughout  organisms, 
including regulation of inflammatory reaction and general immunosuppression, stimulation of 
gluconeogenesis, lipid breakdown and other functions tied with metabolism, ontogenesis or 
immune system. Due to these effects, glucocorticoids are widely used in modern medicine, 
for example, for treatment of rheumatoid arthritis (Hoes et al. 2010).
The  adrenal  gland  is  divided  into  two  distinct  tissues  –  cortex  and  medulla. 
Additionally,  the  gland itself  is  surrounded by a  capsule  of  connective tissue in  order  to 
maintain its structure and shape. Adrenal cortex is made up by three distinct zones. The outer 
zona glomerulosa (ZG), central zona fasciculata (ZF) and inner zona reticularis (ZR). ZG 
synthesizes  mineralocorticoids,  which affect  salt  and water  homeostasis  and ZR produces 
adrenal  androgenes.  ZF  is  the  primary  site  of  glucocorticoid  production  and  is  also 
responsible for small amount of androgen production (Simpson 1988).
Biosynthesis  in  ZF  begins  with  the  transport  of  cholesterol  into  mitochondria,  a 
process regulated by steroidogenic acute regulatory protein (StAR), where it is converted to 
pregnenolone by cholesterol side chain cleavage enzyme P450scc (Miller 1998). This is the 
first  and  rate-limiting  step  in  glucocorticoid  synthesis  and,  therefore,  it  is  the  subject  to 
physiological regulation (Miller 1998). Pregnenolone may be hydroxylated to create 17α-OH-
pregnenolone  and  then  is  converted  to  (17α-OH-)progesterone,  which  undergoes  another 
reaction to form deoxycorticosterone (or deoxycortisol if  17α-OH-progesterone was used) 
and in the final step, deoxycorticosterone or deoxycortisol is converted to corticosterone or 
cortisol (Fig.1). In ZG, corticosterone undergoes one more reaction, forming aldosterone. 
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Fig.1. Overview of important proteins, enzymes and reactions in biosynthetic pathway of glucocorticoids.  
Binding of ACTH onto its receptor induces a signaling cascade promoting gene expression of steroidogenic  
proteins. Abbreviations as following: ACTH – Adrenocorticotropic hormone; PKA -  Protein kinase A; CREB –  
cAMP response element-binding protein; StAR – Steroidogenic acute regulatory protein; CYP11A1 – P450ssc  
cholesterol side-chain cleavage enzyme; CYP17 – steroid 17α-hydroxylase; HSD3B - 3-β-hydroxysteroid  
dehydrogenase; CYP21 - steroid 21-hydroxylase; CYP11B2 steroid 18-hydroxylase (Chung 2011) 
Glucocorticoids act either by binding to the cytoplasmic glucocorticoid receptors, 
forming complexes with chaperone proteins, such as HSP90 (Kumar 2005), or to the 
mineralocorticoid receptors, which bind both glucocorticoids and mineralocorticoids (De 
Kloet et al. 1998). Following ligand binding, the hormone-receptor complex dissociates from 
HSP molecules and is actively transported to nucleus, where it interacts with their respective 
response elements or with other transcription factors (Ray 1993).
One of the key characteristics of glucocorticoid secretory profile that can be detected 
in blood and/or saliva samples, is its pulsatility (Fig.2). Moreover, the highest systemic levels 
are present around the onset of the activity period (i.e. early morning in diurnal, or in the 
evening in nocturnal, species), while the nadir occurs just before the beginning of the rest 
period.
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Fig.2. Representation of a rhythmic corticosterone secretion in male and female Sprague-Dawley rat.  
Horizontal bars represent the dark portion of day. (Lightman et al. 2008)
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3 The Circadian Clocks
 The nature of the circadian clocks and their role in organism has been recognized 
relatively recently in modern biology. The internal timekeeping system allows organism not 
only  to  anticipate  and  prepare  for  regular  changes  in  external  environment,  but  also  to 
separate  their  own  biochemical  processes  (Ishikawa  1976).  The  simplest  circadian  clock 
known so far is present in cyanobacteria and although only consisting of three proteins, it is 
able to produce quite accurate 24-hour oscillations. This clock has been reproduced in vitro 
(Nakajima et al. 2005), which may bring new perspectives to clock research. In mammals, 
circadian  clocks  are  hierarchically  organized  to  form  a  coherent  circadian  system.  The 
presence of a master clock, which is the only clock synchronized by photic input, is necessary 
to drive output behavioral rhythms and keep them synchronized with external light/dark cycle 
(Stephan 1972;  Moore  1972).  Apart  from the  central  clock,  the  mammalian  body houses 
multiple other oscillators with similar makeup in peripheral tissues (Yagita et al. 2001), which 
are continually entrained by the central clock (Yamazaki et al. 2000). 
3.1 The central circadian clock 
The central  circadian oscillator in mammals is  the suprachiasmatic nucleus (SCN), 
which is located in the anterior hypothalamus above the chiasma opticum on both sides of the 
third ventricle (Ralph 1990). The SCN is comprised of two major subdivisions - ventral core 
and  dorsal  shell  region  (Moore  1983).  The  core  region  is  adjacent  to  chiasma  opticum, 
receives direct input from retina and projects to shell region. 
Each  cell  of  the  SCN  is  capable  of  generating  its  own  circadian  rhythm  by 
spontaneous firing of action potentials (Welsh et al. 1995). Importantly, the cells of SCN are 
coupled to form cohesive circadian oscillation. The main tools of this arrangement are action 
potentials  within  the  SCN (Yamaguchi  et  al.  2003).  Oscillations  in  the  dorsal  shell  cells 
exhibit shorter period than those of the entire SCN, while the oscillatory periods of cells in 
ventral  core  region  correspond to  it.  It  has  been  proposed  that  the  dorsal  oscillators  are 
entrained by the ventral  ones (Noguchi  et  al.  2004).  This  also correlates   with numerous 
projections from the ventral to the dorsal SCN, whereas those in opposite direction are quite 
sporadic (Leak 1999). Core neurons produce mostly vasoactive intestinal polypeptide (VIP) 
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or gastrin-releasing peptide (GRP) and project to the shell, which is made up largely from 
neurons  that  produce  arginine  vasopressin  (AVP).  Both  the  core  and  shell  neurons  are 
colocalized with GABA.  The shell region projects to different areas than the core, which are 
localized in other parts of the brain (Moore 2002).
Intact SCN determines the presence of circadian period and of the coherent output 
signals  necessary to  maintain  circadian  rhythmicity.  Transplantation  of  the  SCN tissue  to 
hamsters with SCN lesions restored circadian rhythms of locomotor activity (Lehman et al. 
1987). The length of the restored period depends on donor's genotype and the recipient adopts 
it  (Ralph  et  al.  1990).  However,  transplantation  of  the  SCN  does  not  restore  all  of  the 
recipient's rhythmicity (Meyer-Bernstein et al. 1999), implying that neuronal projections are 
not the only mechanism taking part in the SCN output signals. 
Mammalian  circadian  clockwork  is  made  up  from  interconnected  transcriptional-
translational  feedback  loops  of  a  set  of  genes  and  their  protein  products.  All  cells  in 
mammalian species exhibiting circadian rhythms depend basically on the same basic clock 
mechanism. During the day, proteins of Clock (circadian locomoter output cycles kaput) and 
Bmal1 (brain and muscle aryl hydrocarbon receptor nuclear translocator-like) genes (Gekakis 
et al. 1998) heterodimerise in the cytoplasm and translocate into nucleus, where they bind to  
E-box  sequences  on  promoters  of  various  genes,  including  Per (period)  and  Cry 
(cryptochrome) (Kume et al. 1999). PER and CRY proteins heterodimerise and inhibit their 
own transcription by interacting with CLOCK/BMAL1 dimers (Shearman et al. 2000). The 
PER/CRY dimers decay during the night,  and a new cycle begins  at  onset of a  day.  The 
auxiliary loop regulates Bmal1 transcription by expression of  Rev-Erbα and  RORα, whose 
promoters both contain E-boxes. Their corresponding proteins then compete for binding at 
RORE (retinoic orphan nuclear  receptor  element) on the Bmal1 promoter.  Whereas REV-
ERBα represses Bmal1 transcription, RORα activates it (Guillaumond et al. 2005). Crosstalk 
between these two genes and their proteins thus rhythmically controls Bmal1 expression in 
anti-phase with expression of Per and Cry genes (Fig.3).  
The precision of these mechanisms and period of these oscillations are modulated by 
additional post-translational modifications.  A role of casein kinase 1ε (CK1ε) and FBXL3 
6
protein is to be noted. CKIε phosphorylates BMAL1, PER and CRY proteins and its mutation 
leads  to  a  shortened  period  (Lowrey  et  al.  2000).  BMAL1  is  also  post-translationally 
sumoylated, which supports its rhythmicity (Cardone 2005).  FBXL3 is a protein of the E3 
ubiquitin ligase complex, which degrades CRY1 protein. Mutation of FBXL3 gene has been 
identified  in  a  long  period  (~26 hours)  circadian  mutant,  called  Overtime  or  Afterhours. 
Higher stability of CRY protein in the mutant leads to prolonged CRY-dependent repression 
of the circadian cycle (Siepka et al. 2007; Godinho et al. 2007). 
Fig.3. A model representing the feedback loops of mammalian circadian clockwork. Ccg stands for clock-
controlled genes. (Ko 2006). For abbreviations see text.
When isolated from external time cues, the endogenous period (tau) differs from 24 
hour cycle (T), therefore, organisms need to receive information about the outside conditions 
and entrain their clock accordingly. The most important Zeitgeber (time giver) in organisms is 
light (Roenneberg 1997). Photic signals from the environment are transferred to the SCN via 
intrinsically  photoreceptive  retinal  ganglion  cells  (ipRGCs),  which  utilize  a  pigment 
melanopsin to record external light intensity (Berson 2003). These cells are monosynaptically 
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connected  with  neurons  of  the  core  SCN and  thus  form a  major  pathway to  SCN -  the 
retinohypothalamic tract (RHT). The RHT uses glutamate as neurotransmitter (Ebling 1996). 
Light  activates a  signaling pathway involving phosphorylation of CREB (cAMP response 
element-binding) protein, which is able to induce  Per transcription during subjective night 
(Travnickova-Bendova et al. 2002). The SCN also receives input from intergeniculate leaflet 
(IGL) located in thalamus. The IGL receives projections from the retina and projects to the 
SCN via the geniculohypothalamic tract (GHT) which utilizes neuropeptide Y as its main 
neurotransmitter. The GHT has been attributed to play a role in photoperiodic and non-photic 
entrainment of the SCN (Freeman 2004; Maywood 1997). Another non-photic entrainment 
pathway to the SCN is conveyed by raphe nuclei of the midbrain. Serotonin projected by 
dorsal (DRN) and median (MRN) nuclei modulates SCN response to light (Rea 1994). SCN 
projects diverse output signals to many regions of the brain, as evidenced by experimental 
application of tracers (Watts 1987). SCN also utilizes autonomic nervous system to indirectly 
control several tissues (see below). The overview of output signals and signaling molecules 
exceeds the scope of this work, therefore, only those involved in regulation of glucocorticoid 
secretion will be mentioned in the text below. 
3.2 Peripheral circadian clocks 
Apart from the SCN, the circadian clocks are present in other brain areas and also in 
non-neural  peripheral  tissues  of  the  organism,  including  the  adrenal  gland.   Peripheral 
oscillators in bodily tissues are self-sustained (Yoo et al. 2004). These cellular clocks are not 
coupled in  the same way as  those in the central  clock.  The paracrine signaling has been 
suggested  as  a  possible  alternative  mechanism  of  their  coupling  (Nagoshi  et  al.  2004), 
however, intact SCN is required to keep phases of individual oscillators synchronised with 
each other (Guo et al. 2006). Since mammalian peripheral clocks lack the means to perceive 
photic cues, their main Zeitgeber are various non-photic cues, for example the food intake 
because  feeding activity  usually occurs  during  the  activity period  of  the  animal.  Feeding 
restricted to improper time of a day can alter the phase of the peripheral clocks significantly 
while leaving the phase of the SCN unaffected and, therefore, uncouple the central clock with 
the peripheral ones (Damiola et al. 2000). 
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3.3 Influence of timekeeping on transcriptome
The  circadian  clock  also  shows  a  significant  influence  on  the  organism's  own 
transcriptome (Schaffer et al. 2001). It has been discovered that a significant part of mRNAs 
cycle over the 24-hour period (Storch, 2002). These cycling mRNAs not only represent genes 
involved in the circadian clock mechanism itself, but also genes whose proteins are involved 
in various cellular tasks (Akhtar et al. 2002). These genes are called "clock-controlled genes". 
The circadian signal is transduced via activation of response elements in the gene promoter 
regions,  such  as  E-box  motifs  binding  sites  for  CLOCK/BMAL1,  RORE motifs  binding 
RORE and  REV-ERBα (Ueda  et  al.  2005)  and D-elements  binding DBP (D-site  binding 
protein) (Lavery 1993). 
It should be noted that levels of rhythmic transcripts overlap only slightly between 
tissues (Panda 2002). The clock-controlled genes therefore seem to be not only subjected to 
circadian control  of  gene expression,  but also to  tissue-specific  control.  The central  SCN 
clock  plays  an  important  role  in  entrainment  of  the  transcript  cycling  and  its  ablation 
attenuates or abolishes the rhythms at the tissue or organ level (Sakamoto et al. 1998). 
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4 Circadian regulatory mechanisms of glucocorticoid secretion
The circadian rhythmicity of glucocorticoid secretion has been well known but the 
mechanisms that govern over its regulation are still being researched. These mechanisms can 
be divided into those originating from the central clock in the SCN, and those which are tied 
with the peripheral clock of the adrenal gland.
4.1 HPA axis
The hypothalamic-pituitary-adrenal (HPA) axis is comprised of several elements 
which form a complex system whose main function is to maintain and adjust homeostasis in 
accordance to stress stimuli by regulating organism's behavior and metabolism. The three 
basic elements of the HPA axis are paraventricular nucleus (PVN) of the hypothalamus, 
anterior lobe of the pituitary gland and adrenal cortex. (Chrousos 1992). 
HPA axis action begins with activation of neurons in the paraventricular nucleus of the 
hypothalamus, which results in release of AVP and corticotropin-releasing hormone (CRH) to 
the pituitary. These hormones stimulate median eminence, which controls the synthesis and 
secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary (Watts 2004). 
ACTH  stimulates  glucocorticoid  secretion  in  the  ZF  of  the  adrenal  gland.  Secreted 
glucocorticoids in turn show negative feedback onto the whole system, rapidly inhibiting it by 
nongenomic mechanisms after reaching a threshold (Evanson et al. 2010).
ACTH  is  transported  by  blood  flow  to  the  adrenal  gland,  where  it  binds  to 
adrenocorticotropic  hormone  receptor  (ACTHR)  in  the  ZF.  The  receptor  then  activates 
heterotrimeric G proteins, thus stimulating adenylyl cyclase (Côté et  al.  2001). The rising 
levels  of  intracellular  cAMP then  activate  protein  kinase  A (PKA)  nuclear  transcription 
factors, like cAMP response element binding protein (CREB). The transcription factors then 
modulate  expression  of  genes  involved  in  the  adrenal  glucocorticoid  biosynthesis  (Mayr 
2001).
The  SCN  has  a  significant  role  in  the  regulation  of  HPA  axis  and  thus  the 
glucocorticoid  secretion.  Studies  clearly show that  ablation  of  the  SCN in  rats  abolished 
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circadian  fluctuation  of  glucocorticoid  levels  in  blood  (Abe  et  al.  1979).  SCN-lesioned 
hamsters  provided with  SCN grafts  did  not  show restored  glucocorticoid  rhythms,  which 
shows the importance of axonal connections in their circadian regulation (Meyer-Bernstein et 
al. 1999)
 Projection  from  the  SCN  to  the  medioparvocelullar  (mpPVN)  zone  of  the 
hypothalamus, which contains a subset of neuroendocrine neurons, which produce CRH and 
AVP (Sawchenko  1984),  constitutes  a  direct  regulatory  link  (Vrang  1995),  but  indirect 
projections  to  the  median  eminence  of  the  hypothalamus  are  also  important.  The  SCN 
contacts  the  subparaventricular  (subPVZ)  and  the  dorsomedial  (DMH)  zone  of  the 
hypothalamus, which are directly connected to the mpPVN, which then projects directly onto 
median eminence (Fig.5) (Buijs et al. 2003). 
The levels of glucocorticoids are known to increase after SCN ablation in rats (Buijs 
1993), suggesting an inhibitory role of the central clock in regulation of the HPA axis and 
secretion of glucocorticoids. The inhibitory effect of the SCN on the HPA axis is generally 
attributed to AVP, which is an important neurotransmitter in the SCN projections (Buijs et al. 
1993) towards several areas in the hypothalamus. Studies have shown that infusion of AVP 
into the PVN/DMH zones inhibited corticosterone release in rats with SCN lesions whereas 
administration of AVP antagonist in the same area increased its secretion (Kalsbeek et al. 
1992). 
The role of AVP in the regulation of HPA axis is thus of dualistic nature. Its release 
into  the  median  eminence  from mpPVN stimulates,  but  its  release  into  PVN and  DMH 
inhibits the secretion of glucocorticoids.
These  mechanisms,  however,  are  all  tailored  for  the  nocturnal  rat.  The  circadian 
variations in mRNA levels of AVP have been reported to be similarly phased in the rat and the 
diurnal mice Arvicanthis ansorgei (Dardente et al. 2004). In accordance with results of in vitro 
experiments demonstrating the role of AVP in hypothalamic GABAergic inhibition in rats 
(Hermes  et  al.  2000),  the  proposed  model  now  distinguishes  the  nocturnal  and  diurnal 
mammals (Fig.4). Their circadian regulatory mechanisms of the HPA axis exhibit different 
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innervation. This model explains the inverse effect of AVP action and also explains how the 
excitatory AVP can be part of inhibitory response.
Fig.4. Opposite effects of AVP on the HPA axis in nocturnal (rat) and diurnal (Arvicanthis) animals.  
AVP is released during the light period in both species. In rats, released AVP inhibits the CRH-containing  
neurons in the hypothalamic PVN by contacting GABAergic neurons in the subPVN and DMH. In Arvicanthis 
ansorgei mice, however, the released AVP contacts glutamatergic excitatory neurons in the subPVN and DMH,  
which in turn activates the CRH-containing neurons in the PVN. (Kalsbeek et al. 2012)
However, the described regulation of HPA axis is not by itself sufficient to establish a 
robust rhythm of glucocorticoid levels. The rhythm of ACTH has relatively lower amplitude 
compared with the amplitude of the rhythm in glucocorticoid levels (Watts 2004), suggesting 
a necessity of an additional regulatory mechanisms. It also appears that the intact rhythm of 
glucocorticoids does not solely depend on the rhythmic release of ACTH, since the rhythm 
persisted in hypophysectomized rats receiving ACTH via pellets (Meier 1976).
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4.2 Autonomic nervous system
The  discrepancies  mentioned  above  lead  to  a  belief  that  another  mechanisms 
independent  of  ACTH  secretion  must  exist  in  order  to  produce  the  observed  rhythm. 
Experiments  have  shown  that  the  rhythm  in  plasma  glucocorticoids  may  persist  in 
hypophysectomized  rats,  but  disappears  if  their  adrenal  gland  is  denervated  (Ottenweller 
1982), which further supports a theory of another, neural regulatory mechanism. 
Evidence  for  a  significance  of  the  autonomic  nervous  system in  the  regulation  of 
adrenal  gland  and  its  secretion  of  glucocorticoids  has  been  uncovered  in  a  series  of 
experiments  (Edwards  1993),  which  clashed  with  the  role  of  ACTH  as  the  sole  control 
mechanism of the secretion. The anatomy of the connection of autonomic nervous system and 
SCN was revealed by a transneuronal retrograde virus tracing from adrenal gland (Buijs et al.  
1999). The labeling showed that the adrenal gland is connected to sympathetic neurons in the 
intermediolateral column of the spinal cord (IML), which receives input from neurons in the 
autonomic division of the PVN of the hypothalamus. These neurons receive an input from 
SCN efferents through AVP or VIP (Fig. 5).
The  neural  pathway  enables  regulation  of  glucocorticoid  secretion  by  relaying 
information about  external  light  from the  SCN. Light  exposure alters  adrenal  gland gene 
expression  via  the  SCN  and  the  sympathetic  nervous  system  without  affecting  ACTH 
secretion  (Ishida  et  al.  2005).  This  change  in  gene  expression  is  followed  by change  of 
glucocorticoid levels. The light pulse is  being followed by a rise in adrenaline in adrenal 
gland, which is a candidate molecule for the signal transmission.  This observation is also 
confirmed by the fact that animals with SCN lesion do not exhibit increased adrenal nerve 
activity after light stimulation (Niijima et al. 1993).
The other part of evidence about the regulation via autonomic nervous system is based 
on the finding that the adrenal innervation alters the gland’s sensitivity to ACTH in a diurnal 
manner. The adrenal gland’s sensitivity peaks alongside circulating ACTH levels (Dallman et 
al.  1978). This is also dependent on an intact SCN, as in ablated rats, the ACTH-induced 
corticosterone secretion is shown independent of the time of day (Sage 2002).  Also, adrenal  
denervation led to a decrease of glucocorticoid secretion in the evening in rats (Ulrich-Lai 
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2006).  Thus,  circadian  system also  exerts  its  influence  over  the  glucocorticoid  levels  by 
altering the activity of autonomic nervous system.
Fig.5. Overview of circadian regulatory pathways of glucocorticoid secretion. Black arrows represent  
projections targeting the HPA axis, blue arrows symbolize the ANS pathway. The purple arrow shows projection  
from the DMH to PVN distinct from the SCN-adrenal gland pathway. Clock show presence of autonomous  
circadian pacemakers. (Dickmeis 2009) For abbreviations see text.
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4.3 Adrenal-intrinsic mechanisms
The adrenal gland shows circadian rhythms in metabolic activity and glucocorticoid 
release  in  vitro  without  any  input  from  the  central  clock  (Andrews  1964).  In  later 
experiments,  the clock gene expression has  been uncovered (Lemos 2006),  revealing that 
adrenal gland hosts its own peripheral clock.  This observation became the basis for research 
aimed to uncover the role of the adrenal clock in regulation of glucocorticoid secretion.
As mentioned above, significant portion of the mouse genome is under the influence 
of circadian clock (Oster et al. 2006). Among these genes, there are several components of 
ACTH  signaling  pathway  and  a  few  genes  involved  in  transport  and  biosynthesis  of 
cholesterol. Thus, Oster and colleagues proposed a theory of so-called "gating mechanism" in 
regulation of the glucocorticoid levels. According to their hypothesis, the peripheral clock of 
the adrenal gland  regulates the diurnal rhythm of glucocorticoid production by altering the 
expression of clock-controlled genes in accordance to daytime and thus regulates, i.e., gates,  
its sensitivity to ACTH (Oster et al. 2006). They performed several experiments with adrenal 
cultures from wild-type and Per2/Cry1 mutant mice. The wild-type gland slices exhibited a 
pronounced response to the evening ACTH stimulation, whereas clock-deficient mutant slices 
failed to do so. This finding provides a strong evidence supporting the "gating" mechanism 
(Oster et al. 2006)
One of the mechanisms of how the adrenal clock regulates glucocorticoid secretion is 
by  rhythmic  expression  of  other  genes,  which  are  directly  involved  in  biosynthesis  of 
glucocorticoids. Among the genes, a Steroidogenic acute regulatory protein (StAR) acts as a 
rate-limiting  step  in  the  biosynthetic  pathway  by  transporting  cholesterol  into  the 
mitochondria for the P450scc (Clark et al. 1994). The StAR protein has been shown to have a 
pronounced daily rhythm in expression, which was absent in arrhythmic mutant mice. The 
promoter  of  StAR gene  houses  an  E-box,  so  its  expression  falls  under  control  of 
CLOCK/BMAL1  heterodimer.  The  levels  of  StAR  protein  correspond  with  the  daily 
glucocorticoid levels. These findings implicate that the StAR protein is another possible link 
between the adrenal clock and the steroidogenic pathway (Son et al. 2008).
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5 The influence of glucocorticoids on biological clocks
It is evident that the circadian clocks exert a major influence over the systemic levels 
of  glucocorticoids.  However,  glucocorticoids  themselves  regulate  many  aspects  of  the 
circadian clockwork. This regulation will be reviewed in this chapter.
First,  glucocorticoids  are  believed to  be  involved in  entrainment  of  the  peripheral 
clocks. Treatment of rat fibroblast with dexamethosane, a glucocorticoid receptor agonist, has 
led to induction of circadian gene expression and it also phase shifted clocks in the liver, 
kidney and heart.  In mutant  mice without  glucocorticoid receptor,  dexamethasone did not 
phase-shift  the  clocks,  revealing  that  glucocorticoid  receptor  expression  is  required  for 
dexamethasone-induced phase shifting (Balsalobre et al. 2000). The role of glucocorticoids as 
a timing cue for peripheral clocks is further reinforced by the discovery that from a set of 169 
genes cycling in the mouse liver, 100 of these have lost the circadian rhythmicity of their  
expression  in  adrenalectomised  animals  (Oishi  et  al.  2005).  Glucocorticoids  do  not  only 
regulate  circadian  gene  expression  in  the  peripheral  tissues,  but  also  in  the  brain.  In 
adrenalectomised animals, the PER2 expression rhythm was abolished in oscillator in the oval 
nucleus of the bed nucleus of the stria terminalis (BNST-OV) (Amir et al. 2004). This may 
represent an additional regulation next to projections from the SCN (Leak 2001) because the 
BNST-OV is involved in regulation of behavioral and endocrine responses linked to stress and 
other emotional stimuli. Adrenalectomy did not affect the rhythm in PER2 in other regions of 
the amygdala, (Lamont et al. 2005). The rhythm of PER2 expression has been successfully 
restored in rats after introducing a rhythm in corticosterone via adding it into drinking water. 
Replacing corticosterone by constant-releasing pellets had no effect (Seagall et al. 2006).
Another  regulatory  role  of  glucocorticoids  is  related  with  the  mechanism  of 
entrainment  of  peripheral  clocks  by  the  restricted  feeding  regime.  The  food-entrainable 
oscillator works independently of the central  clock and is  able  to  decouple the phases of 
central and peripheral oscillators in a few days. Temporal limitation of the food availability 
also  increases  animal's  behavioral  activity  in  anticipation  to  food  presentation.  The  food 
anticipatory activity is linked with an increase of adrenal glucocorticoid secretion (Stokkan et 
al. 2001). Glucocorticoids seem to fulfill a regulatory role in decoupling of the central and 
peripheral clocks, because adrenalectomised animals or animals with mutated glucocorticoid 
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receptor gene exhibited faster phase shifting due to exposure to restricted feeding (Le Minh et 
al. 2001).
Cell cycle is another process that is known to exhibit variation dependent on the time 
of day (Bjarnason 1999). Studies on zebrafish larvae have shown that light is an important 
factor able to induce S phase in different cell types across the organism (Dekens et al. 2003). 
Recent research have shown that cell cycle rhythms are less prominent in zebrafish mutants 
with lesser corticotrope pituitary cells. High-amplitude cell cycle rhythms have been rescued 
by introduction of larvae to a tonic concentration of dexamethasone, showing that circadian 
input  from  central  and  peripheral  clocks  is  not  by  itself  enough  to  govern  over  cell 
proliferation across the organism and needs another signal,  specifically glucocorticoids,  to 
properly exert its influence (Dickmeis et al. 2007).
17
6 Clinical aspects of abnormal glucocorticoid secretion
Glucocorticoids  are  essential  molecules,  whose  biosynthesis  and  secretion  are 
necessary for physiological functions of an organism. Abnormal secretion and systemic levels 
of glucocorticoids are associated with many pathological conditions and therefore, a better 
understanding of regulatory mechanisms of glucocorticoid secretion might be beneficial to 
improve treatment of these diseases.
Cushing's  syndrome  is  a  term  describing  various  conditions  associated  with  the 
pathological  elevation  of  systemic  glucocorticoid  levels.  The  diurnal  rhythm  of  plasma 
cortisol is also abolished, implying abnormalities in circadian regulatory mechanisms (Raff 
1998). The symptoms of Cushing's syndrome include central weight gain, thickening of the 
facial  fat,  glucose  intolerance,  hypertension,  general  weakness  and  others.  These  factors 
contribute to the increased mortality of patients with Cushing's syndrome (Steffensen et al. 
2010). The high levels of glucocorticoids can be achieved either by high levels of plasma 
ACTH,  which  stimulate  the  adrenal   gland  (ACTH-dependent  Cushing's  syndrome,  also 
called "Cushing's disease") or by excessive production of glucocorticoids by abnormal cells in 
the  adrenal  gland  (ACTH-independent  Cushing's  syndrome)  (Orth  1995).  Treatment  of 
Cushing's disease is usually transsphenoidal microadenomectomy, which may be followed by 
additional procedures (such as pituitary irradiation) should the first surgery fail. Patients with 
ACTH independent primary adrenal disease require adrenalectomy or treatment with adrenal 
enzyme inhibitors (Orth 1995).
Another  disease  associated  with  dysregulations  in  glucocorticoid  levels  is  chronic 
fatigue syndrome (CFS). Its symptoms are sleep disturbance, impaired concentration, muscle 
and/or  joint  pain,  headaches,  exacerbated  fatigue  after  physical  exertion,  sore  throat  and 
tender  lymph nodes  (Fukuda et  al.  1994).  The cause of  CFS is  not  fully understood, but 
patients  diagnosed  with  CFS exhibit  reinforced  negative  feedback  of  glucocorticoids  and 
hypocortisolism (Cleare 2003).  The disturbances  in  HPA axis,  however,  develop after  the 
onset of CFS. Low cortisol seems to act as one of the maintaining factors of the CFS and low-
dose  replacement  cortisol  therapy has  reported  an  improvement  of  the  symptoms (Cleare 
2004).
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Increased  levels  of  glucocorticoids  and  hyperactivity  of  HPA axis  are  also  well 
recognized  in  patients  suffering  from  depression  (Juruena  et  al.  2006).  This  has  been 
accredited to impaired function of glucocorticoid receptor,  which plays  a  role in negative 
feedback of glucocorticoids on the HPA axis (Anacker et al. 2011). Elevated glucocorticoid 
levels result in decreased hippocampal neurogenesis, which correlates with increased anxiety 
and  depressed  behavior  (Murray  2008).  Discrepancies  in  the  circadian  system  may  be 
responsible  for  malfunctions  in  the  circadian  control  of  HPA axis  and the  glucocorticoid 
secretion, inducing depression.
In  modern  life,  many  professions  require  subjects  to  change  their  daily  routine 
significantly. Night shifts, sleep deprivation, jet lag and irregular eating can lead to chronic 
disruption of  timekeeping system and development  of metabolic  syndromes (Buijs  2006). 
This is defined as a group of conditions that put humans at risk for heart disease, diabetes and 
obesity.  Patients with metabolic syndrome show increased activity of the HPA axis and thus 
are victims of hypercorticolism.  Repairing the dysregulated cortisol secretion by identifying 




Regulation  of  such  a  complex  process  as  secretion  of  adrenal  hormones 
glucocorticoids is deceptively complicated. Several regulatory systems cooperate and impinge 
on the gland to produce a pronounced rhythm in the hormone levels that are capable of acting 
in the whole organisms at different levels. This rhythm may even be interpreted differently in 
various tissues, possibly also dependent on the time of day.
The variation of glucocorticoid levels throughout the day is also an important factor 
needed for negative feedback onto HPA axis, which additionally regulates the secretion of 
glucocorticoids.  Keeping  the  glucocorticoid  secretory  profile  in  its  normal  state  is  very 
important  since  higher  or  lower  concentrations  may  lead  to  development  of  various 
pathologies. Maintaining the proper levels of glucocorticoids is also important in mounting a 
response to stress.
Since a large part  of the present knowledge available  on regulatory mechanism of 
glucocorticoids  has  been  published  relatively recently,  not  everything  is  yet  clear.  A link 
between these health conditions and the rhythm in systemic levels of glucocorticoids has not 
yet been extensively studied. The chronobiological aspects of this research may shed light 




Abe, K., J. Kroning, M. A. Greer, and V. Critchlow. 1979. Effects of destruction of  the 
suprachiasmatic nuclei on the circadian rhythms in plasma corticosterone, body 
temperature, feeding and plasma thyrotropin. Neuroendocrinology 29 (2):119-131.
Akhtar, R. A., A. B. Reddy, E. S. Maywood, J. D. Clayton, V. M. King, A. G. Smith, T. W. 
Gant, M. H. Hastings, and C. P. Kyriacou. 2002. Circadian cycling of the mouse liver 
transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic 
nucleus. Current Biology 12 (7):540-550.
Amir, S., E. W. Lamont, B. Robinson, and J. Stewart. 2004. A circadian rhythm in the 
expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval 
nucleus of the bed nucleus of the stria terminalis. Journal of Neuroscience 24 (4):781-
790.
Anacker, C., P. A. Zunszain, L. A. Carvalho, and C. M. Pariante. 2011. The glucocorticoid 
receptor: Pivot of depression and of antidepressant treatment? 
Psychoneuroendocrinology 36 (3):415-425.
Andrews, R. V., and G. E. Folk. 1964. Circadian metabolic patterns in cultured hamster 
adrenal glands. Comparative Biochemistry and Physiology 11 (4):393-&.
Balsalobre, A., S. A. Brown, L. Marcacci, F. Tronche, C. Kellendonk, H. M. Reichardt, G. 
Schutz, and U. Schibler. 2000. Resetting of circadian time peripheral tissues by 
glucocorticoid signaling. Science 289 (5488):2344-2347.
Berson, D. M. 2003. Strange vision: ganglion cells as circadian photoreceptors. Trends in  
Neurosciences 26 (6):314-320.
Bjarnason, G. A., R. C. K. Jordan, and R. B. Sothern. 1999. Circadian variation in the 
expression of cell-cycle proteins in human oral epithelium. American Journal of  
Pathology 154 (2):613-622.
Buijs, R. M., A. Kalsbeek, T. P. Vanderwoude, J. J. Vanheerikhuize, and S. Shinn. 1993. 
Suprachiasmatic nucleus lesion increases corticosterone secretion. American Journal  
of Physiology 264 (6):R1186-R1192.
Buijs, R. M., and F. Kreier. 2006. The metabolic syndrome: A brain disease? Journal of  
Neuroendocrinology 18 (9):715-716.
Buijs, R. M., M. Markman, B. Nunescardoso, Y. X. Hou, and S. Shinn. 1993. Projections of 
the suprachiasmatic nucleus to stress-related areas in the rat hypothalamus - a light and 
electron-microscopic study. Journal of Comparative Neurology 335 (1):42-54.
21
Buijs, R. M., C. G. van Eden, V. D. Goncharuk, and A. Kalsbeek. 2003. The biological clock 
tunes the organs of the body: timing by hormones and the autonomic nervous system. 
Journal of Endocrinology 177 (1):17-26.
Buijs, R. M., J. Wortel, J. J. van Heerikhuize, M. G. P. Feenstra, G. J. Ter Horst, H. J. Romijn, 
and A. Kalsbeek. 1999. Anatomical and functional demonstration of a multisynaptic 
suprachiasmatic nucleus adrenal (cortex) pathway. European Journal of Neuroscience 
11 (5):1535-1544.
Cardone, L., J. Hirayamna, F. Giordano, T. Tarnaru, J. J. Palvimo, and P. Sassone-Corsi. 2005. 
Circadian clock control by SUMOylation of BMAL1. Science 309 (5739):1390-1394.
Chrousos, G. P., and P. W. Gold. 1992. The concepts of stress and stress system disorders - 
overview of physical and behavioral homeostasis. Jama-Journal of the American 
Medical Association 267 (9):1244-1252.
Chung, S., G. H. Son, and K. Kim. 2011. Circadian rhythm of adrenal glucocorticoid: Its 
regulation and clinical implications. Biochimica Et Biophysica Acta-Molecular Basis  
of Disease 1812 (5):581-591.
Clark, B. J., J. Wells, S. R. King, and D. M. Stocco. 1994. The purification, cloning, and 
expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 
mouse leydig tumor cells. Characterization of the steroidogenic acute regulatory 
protein (StAR). Journal of Biological Chemistry 269 (45):28314-28322.
Cleare, A. J. 2003. The neuroendocrinology of chronic fatigue syndrome. Endocrine Reviews 
24 (2):236-252.
Cleare, A. J. 2004. The HPA axis and the genesis of chronic fatigue syndrome. Trends in  
Endocrinology and Metabolism 15 (2):55-59.
Cote, M., G. Guillon, M. D. Payet, and N. Gallo-Payet. 2001. Expression and regulation of 
adenylyl cyclase isoforms in the human adrenal gland. Journal of Clinical  
Endocrinology & Metabolism 86 (9):4495-4503.
Dallman, M. F., W. C. Engeland, J. C. Rose, C. W. Wilkinson, J. Shinsako, and F. Siedenburg. 
1978. Nycthemeral rhythm in adrenal responsiveness to ACTH. American Journal of  
Physiology 235 (5):R210-R218.
Damiola, F., N. Le Minh, N. Preitner, B. Kornmann, F. Fleury-Olela, and U. Schibler. 2000. 
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central 
pacemaker in the suprachiasmatic nucleus. Genes & Development 14 (23):2950-2961.
Dardente, H., J. S. Menet, E. Challet, B. B. Tournier, P. Pevet, and M. Masson-Pevet. 2004. 
Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of 
22
nocturnal and diurnal rodents. Molecular Brain Research 124 (2):143-151.
De Kloet, E. R., E. Vreugdenhil, M. S. Oitzl, and M. Joels. 1998. Brain corticosteroid receptor 
balance in health and disease. Endocrine Reviews 19 (3):269-301.
Dekens, M. P. S., C. Santoriello, D. Vallone, G. Grassi, D. Whitmore, and N. S. Foulkes. 
2003. Light regulates the cell cycle in zebrafish. Current Biology 13 (23):2051-2057.
Dickmeis, T. 2009. Glucocorticoids and the circadian clock. Journal of Endocrinology 200 
(1):3-22.
Dickmeis, T., K. Lahiri, G. Nica, D. Vallone, C. Santoriello, C. J. Neumann, M. 
Hammerschmidt, and N. S. Foulkes. 2007. Glucocorticoids play a key role in circadian 
cell cycle rhythms. Plos Biology 5 (4):854-864.
Ebling, F. J. P. 1996. The role of glutamate in the photic regulation of the suprachiasmatic 
nucleus. Progress in Neurobiology 50 (2-3):109-&.
Edwards, A. V., and C. T. Jones. 1993. Autonomic control of adrenal-function. Journal of  
Anatomy 183:291-307.
Evanson, N. K., J. G. Tasker, M. N. Hill, C. J. Hillard, and J. P. Herman. 2010. Fast Feedback 
Inhibition of the HPA Axis by Glucocorticoids Is Mediated by Endocannabinoid 
Signaling. Endocrinology 151 (10):4811-4819.
Freeman, D. A., K. M. Dhandapani, and B. D. Goldman. 2004. The thalamic intergeniculate 
leaflet modulates photoperiod responsiveness in Siberian hamsters. Brain Research 
1028 (1):31-38.
Fukuda, K., S. E. Straus, I. Hickie, M. C. Sharpe, J. G. Dobbins, A. Komaroff, A. 
Schluederberg, J. F. Jones, A. R. Lloyd, S. Wessely, N. M. Gantz, G. P. Holmes, D. 
Buchwald, S. Abbey, J. Rest, J. A. Levy, H. Jolson, D. L. Peterson, Jhmm Vercoulen, 
U. Tirelli, B. Evengard, B. H. Natelson, L. Steele, M. Reyes, and W. C. Reeves. 1994. 
The chronic fatigue syndrome : a comprehensive approach to its definition and study. 
Annals of Internal Medicine 121 (12):953-959.
Gekakis, N., D. Staknis, H. B. Nguyen, F. C. Davis, L. D. Wilsbacher, D. P. King, J. S. 
Takahashi, and C. J. Weitz. 1998. Role of the CLOCK protein in the mammalian 
circadian mechanism. Science 280 (5369):1564-1569.
Godinho, S. I. H., E. S. Maywood, L. Shaw, V. Tucci, A. R. Barnard, L. Busino, M. Pagano, 
R. Kendall, M. M. Quwailid, M. R. Romero, J. O'Neill, J. E. Chesham, D. Brooker, Z. 
Lalanne, M. H. Hastings, and P. M. Nolan. 2007. The after-hours mutant reveals a role 
for Fbxl3 in determining mammalian circadian period. Science 316 (5826):897-900.
23
Guillaumond, F., H. Dardente, V. Giguere, and N. Cermakian. 2005. Differential control of 
Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. Journal of  
Biological Rhythms 20 (5):391-403.
Guo, H. G., J. M. Brewer, M. N. Lehman, and E. L. Bittman. 2006. Suprachiasmatic 
regulation of circadian rhythms of gene expression in hamster peripheral organs: 
Effects of transplanting the pacemaker. Journal of Neuroscience 26 (24):6406-6412.
Hermes, Mlhj, J. M. Ruijter, A. Klop, R. M. Buijs, and L. P. Renaud. 2000. Vasopressin 
increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons 
in vitro. Journal of Neurophysiology 83 (2):705-711.
Hoes, J. N., J. W. G. Jacobs, F. Buttgereit, and J. W. J. Bijlsma. 2010. Current view of 
glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nature Reviews 
Rheumatology 6 (12):693-702.
Ishida, A., T. Mutoh, T. Ueyama, H. Bando, S. Masubuchi, D. Nakahara, G. Tsujimoto, and H. 
Okamura. 2005. Light activates the adrenal gland: Timing of gene expression and 
glucocorticoid release. Cell Metabolism 2 (5):297-307.
Ishikawa, K., and T. Shimazu. 1976. Daily rhythms of glycogen-synthetase and phosphorylase 
activities in rat-liver - influences of food and light. Life Sciences 19 (12):1873-1878.
Juruena, M. F., A. J. Cleare, A. S. Papadopoulos, L. Poon, S. Lightman, and C. M. Pariante. 
2006. Different responses to dexamethasone and prednisolone in the same depressed 
patients. Psychopharmacology 189 (2):225-235.
Kalsbeek, A., R. M. Buijs, J. J. Vanheerikhuize, M. Arts, and T. P. Vanderwoude. 1992. 
Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone 
release. Brain Research 580 (1-2):62-67.
Kalsbeek, A., R. van der Spek, J. Lei, E. Endert, R. M. Buijs, and E. Fliers. 2012. Circadian 
rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Molecular and Cellular  
Endocrinology 349 (1):20-29.
Ko, C. H., and J. S. Takahashi. 2006. Molecular components of the mammalian circadian 
clock. Human Molecular Genetics 15:R271-R277.
Kumar, R., and E. B. Thompson. 2005. Gene regulation by the glucocorticoid receptor: 
Structure : function relationship. Journal of Steroid Biochemistry and Molecular  
Biology 94 (5):383-394.
Kume, K., M. J. Zylka, S. Sriram, L. P. Shearman, D. R. Weaver, X. W. Jin, E. S. Maywood, 
M. H. Hastings, and S. M. Reppert. 1999. mCRY1 and mCRY2 are essential 
components of the negative limb of the circadian clock feedback loop. Cell 98 
24
(2):193-205.
Lamont, E. W., B. Robinson, J. Stewart, and S. Amir. 2005. The central and basolateral nuclei 
of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein 
Period2. Proceedings of the National Academy of Sciences of the United States of  
America 102 (11):4180-4184.
Lavery, D. J., and U. Schibler. 1993. Circadian transcription of the cholesterol 7-alpha 
hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes & 
Development 7 (10):1871-1884.
Le Minh, N., F. Damiola, F. Tronche, G. Schutz, and U. Schibler. 2001. Glucocorticoid 
hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. 
Embo Journal 20 (24):7128-7136.
Leak, R. K., J. P. Card, and R. Y. Moore. 1999. Suprachiasmatic pacemaker organization 
analyzed by viral transynaptic transport. Brain Research 819 (1-2):23-32.
Leak, R. K., and R. Y. Moore. 2001. Topographic organization of suprachiasmatic nucleus 
projection neurons. Journal of Comparative Neurology 433 (3):312-334.
Lehman, M. N., R. Silver, W. R. Gladstone, R. M. Kahn, M. Gibson, and E. L. Bittman. 1987. 
Circadian rhythmicity restored by neural transplant - immunocytochemical 
characterization of the graft and its integration with the host brain. Journal of  
Neuroscience 7 (6):1626-1638.
Lemos, D. R., J. L. Downs, and H. F. Urbanski. 2006. Twenty-four-hour rhythmic gene 
expression in the rhesus macaque adrenal gland. Molecular Endocrinology 20 
(5):1164-1176.
Lightman, S. L., C. C. Wiles, H. C. Atkinson, D. E. Henley, G. M. Russell, J. A. Leendertz, 
M. A. McKenna, F. Spiga, S. A. Wood, and B. L. Conway-Campbell. 2008. The 
significance of glucocorticoid pulsatility. European Journal of Pharmacology 583 (2-
3):255-262.
Lowrey, P. L., K. Shimomura, M. P. Antoch, S. Yamazaki, P. D. Zemenides, M. R. Ralph, M. 
Menaker, and J. S. Takahashi. 2000. Positional syntenic cloning and functional 
characterization of the mammalian circadian mutation tau. Science 288 (5465):483-
491.
Mayr, B., and M. Montminy. 2001. Transcriptional regulation by the phosphorylation-
dependent factor CREB. Nature Reviews Molecular Cell Biology 2 (8):599-609.
Maywood, E. S., E. Smith, S. J. Hall, and M. H. Hastings. 1997. A thalamic contribution to 
arousal-induced, non-photic entrainment of the circadian clock of the Syrian hamster. 
25
European Journal of Neuroscience 9 (8):1739-1747.
Meier, A. H. 1976. Daily variation in concentration of plasma corticosteroid in 
hypophysectomized rats. Endocrinology 98 (6):1475-1479.
Meyer-Bernstein, E. L., A. E. Jetton, S. I. Matsumoto, J. F. Markuns, M. N. Lehman, and E. 
L. Bittman. 1999. Effects of suprachiasmatic transplants on circadian rhythms of 
neuroendocrine function in golden hamsters. Endocrinology 140 (1):207-218.
Miller, W. L. 1998. Early steps in androgen biosynthesis: from cholesterol to DHEA. 
Baillieres Clinical Endocrinology and Metabolism 12 (1):67-81.
Moore, R. Y. 1983. Organization and function of a central nervous-system circadian oscillator 
- the suprachiasmatic hypothalamic nucleus. Federation Proceedings 42 (11):2783-
2789.
Moore, R. Y., and V. B. Eichler. 1972. Loss of a circadian adrenal corticosterone rhythm 
following suprachiasmatic lesions in rat. Brain Research 42 (1):201-&.
Moore, R. Y., J. C. Speh, and R. K. Leak. 2002. Suprachiasmatic nucleus organization. Cell  
and Tissue Research 309 (1):89-98.
Murray, F., D. W. Smith, and P. H. Hutson. 2008. Chronic low dose corticosterone exposure 
decreased hippocampal cell proliferation, volume and induced anxiety and depression 
like behaviours in mice. European Journal of Pharmacology 583 (1):115-127.
Nagoshi, E., C. Saini, C. Bauer, T. Laroche, F. Naef, and U. Schibler. 2004. Circadian gene 
expression in individual fibroblasts: Cell-autonomous and self-sustained oscillators 
pass time to daughter cells. Cell 119 (5):693-705.
Nakajima, M., K. Imai, H. Ito, T. Nishiwaki, Y. Murayama, H. Iwasaki, T. Oyarna, and T. 
Kondo. 2005. Reconstitution of circadian oscillation of cyanobacterial KaiC 
phosphorylation in vitro. Science 308 (5720):414-415.
Niijima, A., K. Nagai, N. Nagai, and H. Akagawa. 1993. Effects of light stimulation on the 
activity of the autonomic nerves in anesthetized rats. Physiology & Behavior 54 
(3):555-561.
Noguchi, T., K. Watanabe, A. Ogura, and S. Yamaoka. 2004. The clock in the dorsal 
suprachiasmatic nucleus runs faster than that in the ventral. European Journal of  
Neuroscience 20 (11):3199-3202.
Oishi, K., N. Amagai, H. Shirai, K. Kadota, N. Ohkura, and N. Ishida. 2005. Genome-wide 
expression analysis reveals 100 adrenal gland-dependent circadian genes in the mouse 
liver. DNA Research 12 (3):191-202.
26
Orth, D. N. 1995. Medical progress - cushings-syndrome. New England Journal of Medicine 
332 (12):791-803.
Oster, H., S. Damerow, R. A. Hut, and G. Eichele. 2006. Transcriptional profiling in the 
adrenal gland reveals circadian regulation of hormone biosynthesis genes and 
nucleosome assembly genes. Journal of Biological Rhythms 21 (5):350-361.
Oster, H., S. Damerow, S. Kiessling, V. Jakubcakova, D. Abraham, J. Tian, M. W. Hoffmann, 
and G. Eichele. 2006. The circadian rhythm of glucocorticoids is regulated by a gating 
mechanism residing in the adrenal cortical clock. Cell Metabolism 4 (2):163-173.
Ottenweller, J. E., and A. H. Meier. 1982. Adrenal innervation may be an extrapituitary 
mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 111 
(4):1334-1338.
Panda, S., M. P. Antoch, B. H. Miller, A. I. Su, A. B. Schook, M. Straume, P. G. Schultz, S. A. 
Kay, J. S. Takahashi, and J. B. Hogenesch. 2002. Coordinated transcription of key 
pathways in the mouse by the circadian clock. Cell 109 (3):307-320.
Payne, A. H., and D. B. Hales. 2004. Overview of steroidogenic enzymes in the pathway from 
cholesterol to active steroid hormones. Endocrine Reviews 25 (6):947-970.
Raff, H., J. L. Raff, and J. W. Findling. 1998. Late-night salivary cortisol as a screening test 
for Cushing's syndrome. Journal of Clinical Endocrinology & Metabolism 83 
(8):2681-2686.
Ralph, M. R., R. G. Foster, F. C. Davis, and M. Menaker. 1990. Transplanted suprachiasmatic 
nucleus determines circadian period. Science 247 (4945):975-978.
Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between 
the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. 
Proceedings of the National Academy of Sciences of the United States of America 91 
(2):752-756.
Rea, M. A., J. D. Glass, and C. S. Colwell. 1994. Serotonin modulates photic responses in the 
hamster suprachiasmatic nuclei. Journal of Neuroscience 14 (6):3635-3642.
Roenneberg, T., and R. G. Foster. 1997. Twilight times: Light and the circadian system. 
Photochemistry and Photobiology 66 (5):549-561.
Sage, D., D. Maurel, and O. Bosler. 2002. Corticosterone-dependent driving influence of the 
suprachiasmatic nucleus on adrenal sensitivity to ACTH. American Journal of  
Physiology-Endocrinology and Metabolism 282 (2):E458-E465.
Sakamoto, K., T. Nagase, H. Fukui, K. Horikawa, T. Okada, H. Tanaka, K. Sato, Y. Miyake, 
27
O. Ohara, K. Kako, and N. Ishida. 1998. Multitissue circadian expression of rat period 
homolog (rPer2) mRNA is governed by the mammalian circadian clock, the 
suprachiasmatic nucleus in the brain. Journal of Biological Chemistry 273 (42):27039-
27042.
Sawchenko, P. E., L. W. Swanson, and W. W. Vale. 1984. Co-expression of corticotropin-
releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory 
neurons of the adrenalectomized rat. Proceedings of the National Academy of Sciences  
of the United States of America-Biological Sciences 81 (6):1883-1887.
Schaffer, R., J. Landgraf, M. Accerbi, V. Simon, M. Larson, and E. Wisman. 2001. Microarray 
analysis of diurnal and circadian-regulated genes in Arabidopsis. Plant Cell 13 
(1):113-123.
Segall, L. A., J. S. Perrin, C. D. Walker, J. Stewart, and S. Amir. 2006. Glucocorticoid 
rhythms control the rhythm of expression of the clock protein, Period2, in oval nucleus 
of the bed nucleus of the stria terminalis and central nucleus of the amygdala in rats. 
Neuroscience 140 (3):753-757.
Shearman, L. P., S. Sriram, D. R. Weaver, E. S. Maywood, I. Chaves, B. H. Zheng, K. Kume, 
C. C. Lee, G. T. J. van der Horst, M. H. Hastings, and S. M. Reppert. 2000. Interacting 
molecular loops in the mammalian circadian clock. Science 288 (5468):1013-1019.
Siepka, S. M., S. H. Yoo, J. Park, W. M. Song, V. Kumar, Y. N. Hu, C. Lee, and J. S. 
Takahashi. 2007. Circadian mutant overtime reveals F-box protein FBXL3 regulation 
of cryptochrome and period gene expression. Cell 129 (5):1011-1023.
Simpson, E. R., and M. R. Waterman. 1988. Regulation of the synthesis of steroidogenic 
enzymes in adrenal-cortical cells by ACTH. Annual Review of Physiology 50:427-440.
Son, G. H., S. Chung, H. K. Choe, H. D. Kim, S. M. Baik, H. Lee, H. W. Lee, S. Choi, W. 
Sun, H. Kim, S. Cho, K. H. Lee, and K. Kim. 2008. Adrenal peripheral clock controls 
the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid 
production. Proceedings of the National Academy of Sciences of the United States of  
America 105 (52):20970-20975.
Steffensen, C., A. M. Bak, K. Z. Rubeck, and J. O. L. Jorgensen. 2010. Epidemiology of 
Cushing's Syndrome. Neuroendocrinology 92:1-5.
Stephan, F. K., and I. Zucker. 1972. Circadian-rhythms in drinking behavior and locomotor 
activity of rats are eliminated by hypothalamic-lesions. Proceedings of the National  
Academy of Sciences of the United States of America 69 (6):1583-&.
Stokkan, K. A., S. Yamazaki, H. Tei, Y. Sakaki, and M. Menaker. 2001. Entrainment of the 
circadian clock in the liver by feeding. Science 291 (5503):490-493.
28
Storch, K. F., O. Lipan, I. Leykin, N. Viswanathan, F. C. Davis, W. H. Wong, and C. J. Weitz. 
2002. Extensive and divergent circadian gene expression in liver and heart. Nature 417 
(6884):78-83.
Travnickova-Bendova, Z., N. Cermakian, S. M. Reppert, and P. Sassone-Corsi. 2002. Bimodal 
regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 
activity. Proceedings of the National Academy of Sciences of the United States of  
America 99 (11):7728-7733.
Ueda, H. R., S. Hayashi, W. B. Chen, M. Sano, M. Machida, Y. Shigeyoshi, M. Iino, and S. 
Hashimoto. 2005. System-level identification of transcriptional circuits underlying 
mammalian circadian clocks. Nature Genetics 37 (2):187-192.
Ulrich-Lai, Y. M., M. M. Arnhold, and W. C. Engeland. 2006. Adrenal splanchnic innervation 
contributes to the diurnal rhythm of plasma corticosterone in rats by modulating 
adrenal sensitivity to ACTH. American Journal of Physiology-Regulatory Integrative  
and Comparative Physiology 290 (4):R1128-R1135.
Vrang, N., P. J. Larsen, and J. D. Mikkelsen. 1995. Direct projection from the suprachiasmatic 
nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in 
the paraventricular nucleus of the hypothalamus demonstrated by means of phaseolus-
vulgaris-leukoagglutinin tract tracing. Brain Research 684 (1):61-69.
Walker, B. R. 2006. Cortisol - cause and cure for metabolic syndrome? Diabetic Medicine 23 
(12):1281-1288.
Watts, A. G., and L. W. Swanson. 1987. Efferent projections of the suprachiasmatic nucleus. 
2. studies using retrograde transport of fluorescent dyes and simultaneous peptide 
immunohistochemistry in the rat. Journal of Comparative Neurology 258 (2):230-252.
Watts, A. G., S. Tanimura, and G. Sanchez-Watts. 2004. Corticotropin-releasing hormone and 
arginine vasopressin gene transcription in the hypothalamic paraventricular nucleus of 
unstressed rats: Daily rhythms and their interactions with corticosterone. 
Endocrinology 145 (2):529-540.
Welsh, D. K., D. E. Logothetis, M. Meister, and S. M. Reppert. 1995. Individual neurons 
dissociated from rat suprachiasmatic nucleus express independently phased circadian 
firing rhythms. Neuron 14 (4):697-706.
Yagita, K., F. Tamanini, G. T. J. van der Horst, and H. Okamura. 2001. Molecular mechanisms 
of the biological clock in cultured fibroblasts. Science 292 (5515):278-281.
Yamaguchi, S., H. Isejima, T. Matsuo, R. Okura, K. Yagita, M. Kobayashi, and H. Okamura. 
2003. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 302 
(5649):1408-1412.
29
Yamazaki, S., R. Numano, M. Abe, A. Hida, R. Takahashi, M. Ueda, G. D. Block, Y. Sakaki, 
M. Menaker, and H. Tei. 2000. Resetting central and peripheral circadian oscillators in 
transgenic rats. Science 288 (5466):682-685.
Yoo, S. H., S. Yamazaki, P. L. Lowrey, K. Shimomura, C. H. Ko, E. D. Buhr, S. M. Siepka, H. 
K. Hong, W. J. Oh, O. J. Yoo, M. Menaker, and J. S. Takahashi. 2004. PERIOD2 :: 
LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian 
oscillations in mouse peripheral tissues. Proceedings of the National Academy of  
Sciences of the United States of America 101 (15):5339-5346.
30
